NCT06364865 (AE05ML) is a clinical trial of laparoscopic procedure in Gall Bladder Disease, sponsored by Teleflex.

Who is sponsoring NCT06364865?

NCT06364865 is sponsored by Teleflex.

What drugs are being tested in NCT06364865?

Interventions in NCT06364865: laparoscopic procedure.

What condition does NCT06364865 study?

NCT06364865 studies Gall Bladder Disease, Bile Duct Diseases, Acute Cholecystitis, Kidney, Liver, Appendix, Spleen Disease, Prostate.

Is NCT06364865 still recruiting?

NCT06364865 is currently enrolling by invitation. Last updated 5 August 2025.

Last reviewed 2025-08-05 · How we verify

NCT06364865: AE05ML

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

AE05ML Device for ML Hem-o-lok Polymer Clip Delivery in Laparoscopic Surgical Procedures Observational Registery Study

ENROLLING BY INVITATION Last updated 5 August 2025

What this trial tests

trial testing laparoscopic procedure in Gall Bladder Disease in 161 participants. Enrolling by invitation.

Timeline

7 June 2024

Primary endpoint
27 February 2025

30 August 2025

Quick facts

Lead sponsor	Teleflex
Status	ENROLLING BY INVITATION
Study type	OBSERVATIONAL
Enrollment	161
Start date	7 June 2024
Primary completion	27 February 2025
Estimated completion	30 August 2025
Sites	3 locations across United States

Drugs / interventions tested

laparoscopic procedure

Conditions studied

Gall Bladder Disease — all drugs for Gall Bladder Disease →
Bile Duct Diseases — all drugs for Bile Duct Diseases →
Acute Cholecystitis — all drugs for Acute Cholecystitis →
Kidney — all drugs for Kidney →

Sponsor

Teleflex — full company profile →

Who can join

18 and older, any sex, with Gall Bladder Disease or Bile Duct Diseases. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This clinical registry study aims to evaluate the safety and effectiveness of the AE05ML device for ligating vessels and tissue structures during laparoscopic surgery using Hem-o-lok® Medium Large (ML) polymer clips. The primary objective is to assess the device's safety and performance, with secondary objectives focusing on device performance characteristics and operator feedback.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Teleflex trials

Trials by the same sponsor.

NCT06604039 — A Clinical Registry to Demonstrate the Safety and Performance of Teleflex Vascular Access Devices · recruiting
NCT05702515 — Vascular Positioning System G4 Algorithm ECG Data Collection for Model Training Study · completed
NCT05278507 — Comparing Arrow PICC Catheters w/ Arrowga+rd Blue Advanced Protection Performance and Safety to Unprotected PICC's · NA · unknown

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06364865 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Teleflex
Last refreshed: 5 August 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06364865.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing